UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041439
Receipt number R000047221
Scientific Title An empirical study for establishment of nursing-collaborated community care system, Asahikawa/Hokkaido model, using telemedicine and IoT devices
Date of disclosure of the study information 2020/08/17
Last modified on 2020/08/17 12:16:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An empirical study for establishment of nursing-collaborated community care system, Asahikawa/Hokkaido model, using telemedicine and IoT devices

Acronym

An empirical study for establishment of nursing-collaborated community care system, Asahikawa/Hokkaido model, using telemedicine and IoT devices

Scientific Title

An empirical study for establishment of nursing-collaborated community care system, Asahikawa/Hokkaido model, using telemedicine and IoT devices

Scientific Title:Acronym

An empirical study for establishment of nursing-collaborated community care system, Asahikawa/Hokkaido model, using telemedicine and IoT devices

Region

Japan


Condition

Condition

Sarcopenia, Dysbasia, Dysphagia, Hypertension, Insomnia, Constipation

Classification by specialty

Medicine in general Gastroenterology Geriatrics
Psychiatry Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

It is crucial to establish global medical/care models which enable elderly people to live healthy and securely under rapidly growing proportion of elderly people in the world. To date, community care system has been developed in Japan, however, the system is optimized for urban area but not rural area. Rural areas have less medical resource than urban areas, it is therefore required to establish care system adjusted to rural area.
The aim of this study is to explore the efficacy of telemedicine system with IoT/ICT technique for elderly adult-adjusted medical service, including rehabilitation and patient compliance instruction, on the various conditions in rural areas without enough medical resources.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. Rehabilitation
1) Fall prevention telerehabilitation
The efficacies of the rehabilitation are assessed by Berg Balance Scale (BBS), Timed Up & Go test (TUG test), Hand-held dynamometer (HHD) and Mini-Mental State Examination (MMSE) before and 1, 2 and 3 months after telerehabilitation.

2) Swallowing function evaluation
The efficacies of the rehabilitation are assessed by swallowing sound, tongue pressure, repetitive saliva swallowing test and the number of syllable repetitions of oral diadochokinesis before and 1, 2 and 3 months after rehabilitation.

2. Patient compliance instruction
1) Antihypertensive agents
Vital signs such as blood pressure, pulse and body temperature measured by Internet of Things (IoT) devices are shared with medical staffs. Medical staffs discussed the data and adjust the dosage of antihypertensive agents when necessary. The efficacy of the system is evaluated by measuring the vital signs before and after intervention.

2) Hypnotics
Quality of sleep is quantitatively evaluated by IoT-based bed sensor which can measure sleep time, awaking time, sleep latency, body movements and number of breaths during sleep. Medical staffs discuss the data and adjust the dosage of hypnotic when necessary. The efficacy of the system is evaluated by the quantitative sleep indices before and after the intervention.

3) Laxatives
The information of defecation frequency and fecal property is recorded by ICT devices and shared with medical staffs. Medical staffs discussed the data and adjust the dosage of laxative when necessary. The efficacy of the system is evaluated by the defecation frequency and fecal property before and after the intervention.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

1. Rehabilitation
Medical staffs check the patients' status by telemedicine system and IoT/ICT devices and advise to patients every month at two weeks after the initial intervention.

2. Patient compliance instruction
Medical staff adjusted the dosage of drugs every month based on the data measured by IoT/ICT devices.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Rehabilitation
Patients who are needed rehabilitations

2. Patient compliance instruction
Patients with hypertension, insomnia or constipation

Key exclusion criteria

Patients who are judged to be uneligible for this study due to severe complication or other reasons.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Akitoshi
Middle name
Last name Yoshida

Organization

Asahikawa Medical University

Division name

President of Asahikawa Medical University

Zip code

078-8510

Address

2-1-1-1 Midorigaoka-higashi, Asahikawa, Hokkaido 078-8510, Japan

TEL

0166-65-2111

Email

pyoshida@asahikawa-med.ac.jp


Public contact

Name of contact person

1st name Kentaro
Middle name
Last name Moriichi

Organization

Asahikawa Medical University

Division name

Joint Research Department of Telemedicine and Telecare

Zip code

078-8510

Address

2-1-1-1 Midorigaoka-higashi, Asahikawa, Hokkaido 078-8510, Japan

TEL

0166-68-2693

Homepage URL


Email

morimori@asahikawa-med.ac.jp


Sponsor or person

Institute

Asahikawa Medical University

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency
Kanamic Network Co., Ltd.

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Asahikawa Medical University Research Ethics Committ

Address

2-1-1-1 Midorigaoka-higashi, Asahikawa, Hokkaido 078-8510, Japan

Tel

0166-68-2297

Email

rs-kk.g@asahikawa-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 02 Month 26 Day

Date of IRB

2018 Year 02 Month 26 Day

Anticipated trial start date

2018 Year 02 Month 26 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 08 Month 17 Day

Last modified on

2020 Year 08 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047221


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name